Dear Colleague,

It is with great pleasure that we welcome you to The 2nd International Virtual Congress on Controversies in Fibromyalgia (Fibromyalgia2020).

Even as our understanding regarding the pathogenesis and neuroscience underlying fibromyalgia and chronic pain rapidly expand and proliferate in recent years, heated controversies remain regarding many aspects of fibromyalgia, regarding its place in medicine and society and regarding the best ways to alleviate suffering.

Fibromyalgia2020 follows the success of the inaugural Congress held in Vienna in March 2019 and will expose and shed constructive light on some of these more central controversies, honoring diversity of opinion as well as attempting to forge understanding and a basis for collaboration down the road.

The Congress welcomes researchers, clinicians, Fibromyalgia specialists, treatment experts, pharmaceutical companies and other industry leaders.

We encourage you ask questions via the text box, view the e-posters, network with your fellow delegates, reach out via the chat function and schedule one-to-one meetings with each other.

We thank you for joining us at Fibromyalgia2020.

                                                                                                     

Dr. Jacob Ablin                                                                                                         Prof. Piercarlo Sarzi-Puttini
Tel-Aviv Sourasky Medical Center, Israel                                                                   L. Sacco University Hospital, Milan, Italy